March 15, 2021
No significant safety concerns have been identified with Pfizer/BioNTech’s COVID-19 vaccine in Japan since its rollout in mid-February, two key advisory panels concluded at their first joint meeting to discuss this topic held on March 12. According to the Ministry...read more